442 related articles for article (PubMed ID: 12626580)
1. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
Kochi SK; Johnson RC; Dalmasso AP
J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
4. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
5. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
[TBL] [Abstract][Full Text] [Related]
6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
Joiner KA; Hammer CH; Brown EJ; Frank MM
J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180
[TBL] [Abstract][Full Text] [Related]
9. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
10. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
11. Binding of human and rat CD59 to the terminal complement complexes.
Lehto T; Morgan BP; Meri S
Immunology; 1997 Jan; 90(1):121-8. PubMed ID: 9038722
[TBL] [Abstract][Full Text] [Related]
12. CspA from Borrelia burgdorferi inhibits the terminal complement pathway.
Hallström T; Siegel C; Mörgelin M; Kraiczy P; Skerka C; Zipfel PF
mBio; 2013 Aug; 4(4):. PubMed ID: 23943762
[TBL] [Abstract][Full Text] [Related]
13. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes.
Fernie-King BA; Seilly DJ; Willers C; Würzner R; Davies A; Lachmann PJ
Immunology; 2001 Jul; 103(3):390-8. PubMed ID: 11454069
[TBL] [Abstract][Full Text] [Related]
14. The tick salivary protein Salp15 inhibits the killing of serum-sensitive Borrelia burgdorferi sensu lato isolates.
Schuijt TJ; Hovius JW; van Burgel ND; Ramamoorthi N; Fikrig E; van Dam AP
Infect Immun; 2008 Jul; 76(7):2888-94. PubMed ID: 18426890
[TBL] [Abstract][Full Text] [Related]
15. Single-molecule kinetics of pore assembly by the membrane attack complex.
Parsons ES; Stanley GJ; Pyne ALB; Hodel AW; Nievergelt AP; Menny A; Yon AR; Rowley A; Richter RP; Fantner GE; Bubeck D; Hoogenboom BW
Nat Commun; 2019 May; 10(1):2066. PubMed ID: 31061395
[TBL] [Abstract][Full Text] [Related]
16. CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi.
Kenedy MR; Vuppala SR; Siegel C; Kraiczy P; Akins DR
Infect Immun; 2009 Jul; 77(7):2773-82. PubMed ID: 19451251
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
18. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
[TBL] [Abstract][Full Text] [Related]
19. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.
Alitalo A; Meri T; Rämö L; Jokiranta TS; Heikkilä T; Seppälä IJ; Oksi J; Viljanen M; Meri S
Infect Immun; 2001 Jun; 69(6):3685-91. PubMed ID: 11349031
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.
Kraiczy P; Skerka C; Brade V; Zipfel PF
Infect Immun; 2001 Dec; 69(12):7800-9. PubMed ID: 11705962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
